☰

Antonino Passaniti

Affiliations: 
Biochemistry University of Maryland School of Medicine, Baltimore, MD, United States 
Area:
Oncology, Biochemistry
Google:
"Antonino Passaniti"
Mean distance: (not calculated yet)
 
Tree Publications Similar researchers PubMed Report error

Parents

Sign in to add mentor

Children

Sign in to add trainee
Michele I. Vitolo grad student 2004 University of Maryland Medical School
Adam D. Pierce grad student 2011 University of Maryland Medical School
Moran Choe grad student 2013 University of Maryland Medical School
Jessica L. Brusgard grad student 2014 University of Maryland Medical School

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Passaniti A, Kim MS, Polster BM, et al. (2022) Targeting mitochondrial metabolism for metastatic cancer therapy. Molecular Carcinogenesis
Blanchard TG, Czinn SJ, Banerjee V, et al. (2019) Identification of Cross Talk between FoxM1 and RASSF1A as a Therapeutic Target of Colon Cancer. Cancers. 11
Kim MS, Gernapudi R, Cedeno YC, et al. (2019) Abstract 794: Inhibition of mitochondrial metabolism by a novel agent targeting RUNX2-DNA binding in breast cancer Cancer Research. 79: 794-794
Kim MS, Gernapudi R, Choi EY, et al. (2017) Characterization of CADD522, a small molecule that inhibits RUNX2-DNA binding and exhibits antitumor activity. Oncotarget. 8: 70916-70940
Passaniti A, Brusgard JL, Qiao Y, et al. (2017) Roles of RUNX in Hippo Pathway Signaling. Advances in Experimental Medicine and Biology. 962: 435-448
Twum-Ampofo J, Fu DX, Passaniti A, et al. (2016) Metabolic targets for potential prostate cancer therapeutics. Current Opinion in Oncology
Li Z, Yang Z, Passaniti A, et al. (2016) A positive feedback loop involving EGFR/Akt/mTORC1 and IKK/NF-kB regulates head and neck squamous cell carcinoma proliferation. Oncotarget
Kim, Choe M, Cho H, et al. (2016) Abstract P5-05-02: Regulation of glucose metabolism by the RUNX2 transcription factor has a negative impact on mitochondrial function in breast cancer cells Cancer Research. 76
Brusgard JL, Choe M, Chumsri S, et al. (2015) RUNX2 and TAZ-dependent signaling pathways regulate soluble E-Cadherin levels and tumorsphere formation in breast cancer cells. Oncotarget. 6: 28132-50
Choe M, Brusgard JL, Chumsri S, et al. (2015) The RUNX2 Transcription Factor Negatively Regulates SIRT6 Expression to Alter Glucose Metabolism in Breast Cancer Cells. Journal of Cellular Biochemistry
See more...